Amphix Bio | $12,500,000 | (Dec 19, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
Katalist | $1,500,000 | (Dec 19, 2025)
Cadenza Bio
United States
- Oklahoma City
- 18/12/2023
- Seed
- $2,440,000
Cadenza Bio, Inc. was founded in 2022 to accelerate and support the development of a series of novel, non-steroidal, highly selective compounds targeting Estrogen Receptor β (ERβ). Our patented and patent-pending compounds have shown therapeutic efficacy in preclinical animal models of Multiple Sclerosis and Endometriosis.
Our goal goes beyond incremental improvements. We are dedicated to breaking the cycle of disease and, in doing so, transforming lives. We aim not only to alleviate symptoms but to halt progression, promote repair, and restore quality of life to enable total activity, empowering patients to regain control over their health.
- Industry Biotechnology Research
- Website https://www.cadenza.bio/
- LinkedIn https://www.linkedin.com/company/cadenza-bio/
Related People
Carol CurtisCo Founder
United States -
Oklahoma City, Oklahoma
Knowledge and experience in technology transfer, patenting and licensing of inventions, project management, early stage venture management consulting, pre-investment risk analysis/due diligence and venture capital investing.
Syremis Therapeutics | $165,000,000 | (Dec 19, 2025)
Gravity Labs Co., Ltd. | $17,000,000 | (Dec 19, 2025)
Edison Scientific | $70,000,000 | (Dec 19, 2025)
InfiniteWatch | $4,000,000 | (Dec 19, 2025)
Thread | $18,000,000 | (Dec 19, 2025)
Neural Concept | $100,000,000 | (Dec 19, 2025)
SkillCorner | $60,000,000 | (Dec 19, 2025)
Wearlinq | $14,000,000 | (Dec 18, 2025)
T-CURX GmbH | $20,000,000 | (Dec 18, 2025)